Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Tower Semiconductor Announces First Quarter 2026 Financial Results and Conference Call

globenewswire.com
TSEM

H.I.G. WhiteHorse stellt der Globe Groupe Finanzierung zur Verfügung USA - Deutsch USA - English USA - Français USA - Nederlands USA - English

prnewswire.com
HIG

H.I.G. WhiteHorse accorde un financement à Globe Groupe USA - Français USA - Deutsch USA - English USA - Nederlands USA - English

prnewswire.com
HIG

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

globenewswire.com
BDSX

OwlTing Group (NASDAQ: OWLS) Announces 12-Month Lock-Up Extension Supported by SBI and Legacy Shareholders Representing More Than 99% of Subject Shares

globenewswire.com
OWLS

OwlTing Group (NASDAQ: OWLS) Announces 12-Month Lock-Up Extension Supported by SBI and Legacy Shareholders Representing More Than 99% of Subject Shares

globenewswire.com
OWLS

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026

globenewswire.com
GLSI

USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader

globenewswire.com
USARW USAR

Tower Semiconductor Announces First Quarter 2026 Financial Results and Conference Call

globenewswire.com
TSEM

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026

globenewswire.com
PRLD
View all news →